Optimizing screening assays for 2nd generation therapeutics targeting neurodegenerative disorders, enhancing candidate selection pipeline. Conducting advanced protein-protein interaction assays to elucidate drug mechanisms, focusing on impacts on mitochondrial quality control. Collecting and analyzing critical data for a scientific startup and delivering presentations at company meetings to drive strategic decisions

Optimizing a 3D cell culture model that screens whether prostate cancer-associated mutations enhance cellular survival in hypoxia conditions, providing insight into the role of hypoxia in prostate tumor evolution.

Facilitated collaborative & inclusive learning, growth mindset, and metacognition in weekly discussion sections, lectures, and CLC problem-solving sections. Designed creative study techniques for peers. Work to minimize impacts of educational disparities on peers.

Developed and presented a 25 page research report investigating Trop2 protein’s relevance to cancer. Analyzed gene protein sequence, isoforms, gene variants, protein structure, orthologs, copy number, and mutation profile via bioinformatic tools.Developed formal research report & presentation on Chronic Myeloid Leukemia covering anatomy, phases, genetic changes, signaling pathways, risk factors, diagnosis, preventive procedures, and emerging therapies. Presentation quality ranked #1 intern out of 25 peers. Reviewed 25 intern reports on various cancers, enhancing scientific review skills and identification of strengths and weaknesses in scientific writing.Engaged in tri-weekly, 4-hour discussions with 40+ Pharma/Biotech experts, acquiring insights into developments in drug discovery, clinical trials, regulatory compliance, and emerging technologies shaping the pharmaceutical and biotechnology industries.

Intern at Health Pals, a biotechnology startup utilizing AI to develop clinically actionable insights to better chronic disease prevention, diagnosis, and treatment response. Aided in development of dashboard to present clinical findings to Health Pals clients. Provided new feedback on Health Pals’ reports made for drug companies proceeding with clinical trials. Learned about statistical qualitative and quantitative analysis of patient data.

Shadowed Dr. Rajesh Dash, Medical & Scientific Director at SSATHI, an initiative to gain insight on cardiovascular disease risk factors for South Asians and develop targeted patient treatment plans which incorporate telemedicine. Co-authored article concerning pros & cons of telemedicine and researched its changing use, especially through COVID-19 pandemic. Interviewed & emailed to gather data from Stanford students, SSATHI clinic, Stanford Medicine, and Stanford Healthcare. Submitted article for publication in Stanford Medicine’s blog SCOPE.